The companies have identified an initial set of genetic biomarkers to predict drug response and will validate the findings in ...
BobcatBio brought on the contract development and manufacturing organization to support manufacturing for ongoing Phase I studies in lymphoma and solid tumors.
The Shenzhen, China-based biotech plans to launch a Phase I trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IN026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results